Related Experiment Video

Updated: Aug 18, 2026

Laser-Induced Action Potential-Like Measurements of Cardiomyocytes on Microelectrode Arrays for Increased Predictivity of Safety Pharmacology
10:41

Laser-Induced Action Potential-Like Measurements of Cardiomyocytes on Microelectrode Arrays for Increased Predictivity of Safety Pharmacology

Published on: September 13, 2022

The effect of magnesium sulfate on action potential duration and cardiac arrhythmias

John C Somberg1, Wei Cao, Ivana Cvetanovic

  • 1Division of Clinical Pharmacology, Rush University, Chicago, Illinois, USA. jsomberg@rush.edu

American Journal of Therapeutics
|May 14, 2005
PubMed

Insights

Magnesium sulfate (MgSO4) infusion prolonged cardiac repolarization intervals (QT, JT) in rats, demonstrating significant antiarrhythmic effects against induced ventricular arrhythmias like ventricular tachycardia and fibrillation.

Area of Science:

  • Cardiovascular Electrophysiology
  • Pharmacology
  • Cardiac Arrhythmia Research

Background:

  • Cardiac arrhythmias pose a significant clinical challenge.
  • Magnesium's role in cardiac electrophysiology is not fully elucidated.
  • Understanding magnesium's effects is crucial for developing antiarrhythmic strategies.

Purpose of the Study:

  • To investigate the electrophysiologic and antiarrhythmic effects of magnesium sulfate (MgSO4) infusion in a rat model.
  • To assess the impact of MgSO4 on cardiac action potential duration (APD) and key electrocardiogram intervals.

Main Methods:

  • Rats were infused with either MgSO4 (15 mg/h) or saline, with electrocardiograms and APD recorded.
  • Measurements were taken at 15-minute intervals over a 2-hour infusion period.
  • Myocardial infarction was induced to provoke ventricular arrhythmias, and their incidence was compared between groups.

Main Results:

  • MgSO4 infusion significantly increased QT interval (15 +/- 6%) and JT interval compared to saline (P < 0.01).
  • Action potential duration (APD) showed a significant increase in the MgSO4 group (12 +/- 8%) versus saline (1 +/- 3%) (P < 0.05).
  • Rats receiving MgSO4 exhibited significantly fewer ventricular premature contractions, ventricular tachycardia, and ventricular fibrillation episodes post-coronary occlusion compared to controls.

Conclusions:

  • MgSO4 infusion prolongs QRS, QT, and JT intervals in rats, indicating altered cardiac repolarization.
  • These electrophysiologic changes correlate with marked suppression of induced ventricular arrhythmias.
  • Magnesium sulfate demonstrates significant antiarrhythmic potential, warranting further investigation for clinical application.

More Related Videos

Isolation of Human Ventricular Cardiomyocytes from Vibratome-Cut Myocardial Slices11:19

Isolation of Human Ventricular Cardiomyocytes from Vibratome-Cut Myocardial Slices

Published on: May 10, 2020

Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice09:20

Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice

Published on: July 5, 2021

Related Concept Videos

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class II Agents as &#946;-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
Cardiac Action Potential01:30

Cardiac Action Potential

Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials